Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Balatti

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|February 27, 2020
Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic LeukemiaFelice Pepe, Veronica Balatti
Cancers|February 15, 2022
Small Non-Coding RNAs in LeukemiaVeronica Balatti, Carlo M Croce
Advances in Biological Regulation|October 24, 2019
MicroRNA dysregulation and multi-targeted therapy for cancer treatmentVeronica Balatti, Carlo M Croce
Journal of Hematology & Oncology|April 18, 2015
Role of microRNA in chronic lymphocytic leukemia onset and progressionVeronica Balatti, Yuri Pekarky, Carlo M Croce
Advances in Cancer Research|September 9, 2017
Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for TherapyVeronica Balatti, Yuri Pekarsky, Carlo M Croce
Cell Death and Differentiation|October 7, 2017
BCL2 and miR-15/16: from gene discovery to treatmentYuri Pekarsky, Veronica Balatti, Carlo M Croce
Journal of Cell Communication and Signaling|August 29, 2022
tRNA-derived fragments (tRFs) in cancerYuri Pekarsky, Veronica Balatti, Carlo M Croce
Applied and Environmental Microbiology|August 30, 2008
Gram-negative bacterial lipopolysaccharide retention by a positively charged new-generation filterIlaria Bononi, Veronica Balatti, Soccorso Gaeta, et al.
Trends in Cancer|May 24, 2016
Novel mechanisms of regulation of miRNAs in CLLVeronica Balatti, Mario Acunzo, Yuri Pekarky, et al.
Oncotarget|February 22, 2012
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemiaRosa Visone, Angelo Veronese, Veronica Balatti, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|February 27, 2020
Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic LeukemiaFelice Pepe, Veronica Balatti
Cancers|February 15, 2022
Small Non-Coding RNAs in LeukemiaVeronica Balatti, Carlo M Croce
Advances in Biological Regulation|October 24, 2019
MicroRNA dysregulation and multi-targeted therapy for cancer treatmentVeronica Balatti, Carlo M Croce
Journal of Hematology & Oncology|April 18, 2015
Role of microRNA in chronic lymphocytic leukemia onset and progressionVeronica Balatti, Yuri Pekarky, Carlo M Croce
Advances in Cancer Research|September 9, 2017
Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for TherapyVeronica Balatti, Yuri Pekarsky, Carlo M Croce
Cell Death and Differentiation|October 7, 2017
BCL2 and miR-15/16: from gene discovery to treatmentYuri Pekarsky, Veronica Balatti, Carlo M Croce
Journal of Cell Communication and Signaling|August 29, 2022
tRNA-derived fragments (tRFs) in cancerYuri Pekarsky, Veronica Balatti, Carlo M Croce
Applied and Environmental Microbiology|August 30, 2008
Gram-negative bacterial lipopolysaccharide retention by a positively charged new-generation filterIlaria Bononi, Veronica Balatti, Soccorso Gaeta, et al.
Trends in Cancer|May 24, 2016
Novel mechanisms of regulation of miRNAs in CLLVeronica Balatti, Mario Acunzo, Yuri Pekarky, et al.
Oncotarget|February 22, 2012
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemiaRosa Visone, Angelo Veronese, Veronica Balatti, et al.
Pageof 5